GlobalData tracks 19 drugs in development for Cataract by 17 companies/universities/institutes. The top development phase for Cataract is preclinical, with 13 drugs in that stage.
Despite setback, AbbVie’s big bet on neuroscience has yet to play out
For AbbVie, the good news this week is that the failure of a high-profile schizophrenia drug in two key trials hardly marks its last opportunity